Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Fish and Richardson
Johnson and Johnson
Merck
Colorcon
Dow
Covington
UBS

Generated: May 21, 2018

DrugPatentWatch Database Preview

VANCOR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Vancor patents expire, and what generic alternatives are available?

Vancor is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in VANCOR is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for VANCOR
Drug patent expirations by year for VANCOR
Medical Subject Heading (MeSH) Categories for VANCOR
Synonyms for VANCOR
(S)-3,6-Diamino-hexanoic acid {(3S,9S,12S,15S)-3-((S)-6-hydroxy-2-imino-hexahydro-pyrimidin-4-yl)-9,12-bis-hydroxymethyl-2,5,8,11,14-pentaoxo-6-[1-ureido-meth-(Z)-ylidene]-1,4,7,10,13pentaaza-cyclohexadec-15-yl}-amide
[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-(2-amino-2-oxo-ethyl)-dichloro-pentahydroxy-[[(2R)-4-
[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-(2-amino-2-oxo-ethyl)-dichloro-pentahydroxy-[[(2R)-4-methyl-2-(methylamino)pen
1404-90-6
1404-93-9 (hydrochloride)
4-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole
404V906
6465-EP1441224A2
6465-EP2277898A2
6465-EP2295402A2
6465-EP2298762A2
6465-EP2305657A2
6465-EP2305662A1
6465-EP2308479A2
64685-75-2 (sulfate)
6Q205EH1VU
AB22390
AC1L24VU
AC1Q29OH
ACT02696
AKOS030526092
AN-49151
BDBM50335519
C06689
C66H75Cl2N9O24
CCG-205340
CHEBI:28001
CHEMBL262777
CHEMBL3735877
Chloroorienticin B derivative
CS-3242
D00212
D0B1IV
DB00512
Diatracin
EINECS 215-772-6
Glycopeptide Antibiotic
HSDB 3262
HY-B0671
Lopac0_001267
LS-161387
Mannopeptimycin Glycopeptide
Mannopeptimycin glycopeptide analogue
methyl-2-(methylamino)pentanoyl]amino]-pentaoxo-[?]carboxylic acid
MYPYJXKWCTUITO-LYRMYLQWSA-N
N-demethylvancomycin derivative
Poly ethylene glycol derivative
Prestwick0_000497
Prestwick1_000497
Prestwick2_000497
SCHEMBL3177
SPBio_002314
SR-01000076194
SR-01000076194-5
Tuberactinomycin Analogue
UNII-6Q205EH1VU
Vancocin
Vancocin HCL
Vancocine
Vancoled
vancomicin
Vancomicina
Vancomicina [INN-Spanish]
VANCOMYCIN
Vancomycin (oral, MRSA), AuricX
Vancomycin (oral/pill, MSRA)
Vancomycin (oral/pill, MSRA), AuricX/SRI International
Vancomycin (USP)
Vancomycin [USAN:INN:BAN]
Vancomycin [USP:INN:BAN]
Vancomycin HCL
Vancomycin hydrochloride from Streptomyces orientalis
Vancomycine
Vancomycine [INN-French]
Vancomycinum
Vancomycinum [INN-Latin]
vanomycin
Viomycin derivative

US Patents and Regulatory Information for VANCOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn VANCOR vancomycin hydrochloride INJECTABLE;INJECTION 062956-002 Aug 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn VANCOR vancomycin hydrochloride INJECTABLE;INJECTION 062956-001 Aug 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
AstraZeneca
Chubb
Cerilliant
Argus Health
Accenture
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.